Effects of bladder resorption on pharmacokinetic data analysis

Area of Science:

• Pharmacokinetics
• Drug Metabolism and Elimination
• Computational Biology

Background:

• The urinary bladder is often modeled as a simple storage site for renally excreted compounds.
• Previous research suggests significant drug reabsorption from the bladder into circulation.
• The quantitative impact of bladder resorption on pharmacokinetic parameters requires detailed investigation.

Purpose of the Study:

• To evaluate the importance of determinants of bladder resorption using computer simulations.
• To assess the errors in pharmacokinetic parameters introduced by omitting bladder resorption.
• To identify the most sensitive pharmacokinetic parameters affected by bladder resorption.

Main Methods:

• Computer simulations were employed to model drug excretion and bladder resorption.
• Key determinants simulated included bladder resorption rate constant (ka), voiding interval (delta tvoid), and elimination rate constant ratios (kex:kel).
• Pharmacokinetic parameters (CLrenal, CLtotal, t1/2, MRT, Aex, fe, Vdss) were derived from simulated profiles.

Main Results:

• Bladder resorption alters plasma and urinary excretion profiles.
• Key determinants of resorption extent and rate are ka, delta tvoid, and kex:kel ratio.
• Omission of bladder resorption led to overestimation of MRT and t1/2, and underestimation of CLrenal, CLtotal, Aex, and fe.

Conclusions:

• Bladder resorption significantly influences pharmacokinetic profiles and derived parameters.
• Erroneous omission of bladder resorption leads to substantial over- or underestimation of pharmacokinetic metrics.
• CLrenal and fe are highly sensitive parameters, showing significant underestimation when bladder resorption is ignored.